Literature DB >> 24389148

Molecular determinants for a cardiovascular collapse in anthrax.

Jurgen Brojatsch1, Arturo Casadevall1, David L Goldman1.   

Abstract

Bacillus anthracis releases two bipartite proteins, lethal toxin and edema factor, that contribute significantly to the progression of anthrax-associated shock. As blocking the anthrax toxins prevents disease, the toxins are considered the main virulence factors of the bacterium. The anthrax bacterium and the anthrax toxins trigger multi-organ failure associated with enhanced vascular permeability, hemorrhage and cardiac dysfunction in animal challenge models. A recent study using mice that either lacked the anthrax toxin receptor in specific cells and corresponding mice expressing the receptor in specific cell types demonstrated that cardiovascular cells are critical for disease mediated by anthrax lethal toxin. These studies are consistent with involvement of the cardiovascular system, and with an increase of cardiac failure markers observed in human anthrax and in animal models using B. anthracis and anthrax toxins. This review discusses the current state of knowledge regarding the pathophysiology of anthrax and tries to provide a mechanistic model and molecular determinants for the circulatory shock in anthrax.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24389148      PMCID: PMC4294697          DOI: 10.2741/e697

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  90 in total

1.  The chemical basis of the virulence of bacillus anthracis. II. Some biological properties of bacterial products.

Authors:  J KEPPIE; H SMITH; P W HARRIS-SMITH
Journal:  Br J Exp Pathol       Date:  1953-10

2.  Sepsis and pathophysiology of anthrax in a nonhuman primate model.

Authors:  Deborah J Stearns-Kurosawa; Florea Lupu; Fletcher B Taylor; Gary Kinasewitz; Shinichiro Kurosawa
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

3.  Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.

Authors:  N S Duesbery; C P Webb; S H Leppla; V M Gordon; K R Klimpel; T D Copeland; N G Ahn; M K Oskarsson; K Fukasawa; K D Paull; G F Vande Woude
Journal:  Science       Date:  1998-05-01       Impact factor: 47.728

4.  Caspase-1 activation of IL-1beta and IL-18 are essential for Shigella flexneri-induced inflammation.

Authors:  P J Sansonetti; A Phalipon; J Arondel; K Thirumalai; S Banerjee; S Akira; K Takeda; A Zychlinsky
Journal:  Immunity       Date:  2000-05       Impact factor: 31.745

5.  Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model.

Authors:  Xizhong Cui; Yan Li; Xuemei Li; Michael W Laird; Mani Subramanian; Mahtab Moayeri; Stephen H Leppla; Yvonne Fitz; Junwu Su; Kevin Sherer; Peter Q Eichacker
Journal:  J Infect Dis       Date:  2007-01-03       Impact factor: 5.226

Review 6.  Pyroptosis and host cell death responses during Salmonella infection.

Authors:  Susan L Fink; Brad T Cookson
Journal:  Cell Microbiol       Date:  2007-08-20       Impact factor: 3.715

7.  B. anthracis edema toxin increases cAMP levels and inhibits phenylephrine-stimulated contraction in a rat aortic ring model.

Authors:  Yan Li; Xizhong Cui; Steven B Solomon; Kenneth Remy; Yvonne Fitz; Peter Q Eichacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

8.  Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin.

Authors:  J L Erwin; L M DaSilva; S Bavari; S F Little; A M Friedlander; T C Chanh
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

9.  Bacillus anthracis cell wall produces injurious inflammation but paradoxically decreases the lethality of anthrax lethal toxin in a rat model.

Authors:  Xizhong Cui; Junwu Su; Yan Li; Joseph Shiloach; Steven Solomon; Jeanne B Kaufman; Haresh Mani; Yvonne Fitz; Jia Weng; Laith Altaweel; Virginia Besch; Peter Q Eichacker
Journal:  Intensive Care Med       Date:  2009-09-15       Impact factor: 17.440

10.  Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax.

Authors:  Nutan Mytle; Robert J Hopkins; Nina V Malkevich; Subhendu Basu; Gabriel T Meister; Daniel C Sanford; Jason E Comer; Kristopher E Van Zandt; Mohamed Al-Ibrahim; William G Kramer; Cris Howard; Nancy Daczkowski; Ajoy C Chakrabarti; Boris Ionin; Gary S Nabors; Mario H Skiadopoulos
Journal:  Antimicrob Agents Chemother       Date:  2013-08-26       Impact factor: 5.191

View more
  8 in total

1.  Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.

Authors:  Shay Weiss; Zeev Altboum; Itai Glinert; Josef Schlomovitz; Assa Sittner; Elad Bar-David; David Kobiler; Haim Levy
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

2.  Soluble P-selectin rescues mice from anthrax lethal toxin-induced mortality through PSGL-1 pathway-mediated correction of hemostasis.

Authors:  Der-Shan Sun; Yao-Wen Chang; Jyh-Hwa Kau; Hsin-Hsien Huang; Pei-Hsun Ho; Yin-Jeh Tzeng; Hsin-Hou Chang
Journal:  Virulence       Date:  2017-01-19       Impact factor: 5.882

3.  Distinct cathepsins control necrotic cell death mediated by pyroptosis inducers and lysosome-destabilizing agents.

Authors:  Jürgen Brojatsch; Heriberto Lima; Deborah Palliser; Lee S Jacobson; Stefan M Muehlbauer; Raquel Furtado; David L Goldman; Michael P Lisanti; Kartik Chandran
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  A Biologically-Based Computational Approach to Drug Repurposing for Anthrax Infection.

Authors:  Jane P F Bai; Theodore Sakellaropoulos; Leonidas G Alexopoulos
Journal:  Toxins (Basel)       Date:  2017-03-10       Impact factor: 4.546

5.  Multiple stages of evolutionary change in anthrax toxin receptor expression in humans.

Authors:  Lauren A Choate; Gilad Barshad; Pierce W McMahon; Iskander Said; Edward J Rice; Paul R Munn; James J Lewis; Charles G Danko
Journal:  Nat Commun       Date:  2021-11-15       Impact factor: 14.919

Review 6.  Does Bacillus anthracis Lethal Toxin Directly Depress Myocardial Function? A Review of Clinical Cases and Preclinical Studies.

Authors:  Dante A Suffredini; Hanish Sampath-Kumar; Yan Li; Lernik Ohanjanian; Kenneth E Remy; Xizhong Cui; Peter Q Eichacker
Journal:  Toxins (Basel)       Date:  2015-12-12       Impact factor: 4.546

7.  A proteolytic cascade controls lysosome rupture and necrotic cell death mediated by lysosome-destabilizing adjuvants.

Authors:  Jürgen Brojatsch; Heriberto Lima; Alak K Kar; Lee S Jacobson; Stefan M Muehlbauer; Kartik Chandran; Felipe Diaz-Griffero
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

8.  A Comparison of the Adaptive Immune Response between Recovered Anthrax Patients and Individuals Receiving Three Different Anthrax Vaccines.

Authors:  Thomas R Laws; Tinatin Kuchuloria; Nazibriola Chitadze; Stephen F Little; Wendy M Webster; Amanda K Debes; Salome Saginadze; Nikoloz Tsertsvadze; Mariam Chubinidze; Robert G Rivard; Shota Tsanava; Edward H Dyson; Andrew J H Simpson; Matthew J Hepburn; Nino Trapaidze
Journal:  PLoS One       Date:  2016-03-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.